Archives

by in
Entry Author Date Location
Exelixis Bags $156M, Tethys Bets on Prevention, UCSF’s Delicate Dance With Industry, & More Bay Area Life Sciences News 03/11/11 San Francisco
Exelixis Pockets $156M in Stock Sale, Riding Wave of Prostate Cancer Drug Results 03/09/11 San Francisco
Big Pharma’s Hardball Tactics Won’t Kill Biotech, But They Could Kill Off Some Pharmas 02/28/11 National
Testing Experimental Drugs in Combination – A New Trend 12/22/10 San Diego
Roche Cutting Hundreds of Jobs, Exelixis Shares Soar, Sutro Pockets $36.5M, & More Bay Area Life Sciences News 11/19/10 San Francisco
Exelixis Shares Soar on Cancer Results 11/18/10 San Francisco
Biogen Idec Axes 650 Jobs, Closes San Diego Site, Bets Future on Neurology 11/03/10 Boston
Exelixis Seeks to Exit Doghouse, Sangamo Morphs Into Drugmaker, Siluria Adds $13M, & More Bay Area Life Sciences News 10/22/10 San Francisco
Exelixis Seeks to Climb From the Penalty Box, Prove its Lead Drug Still Has Legs 10/20/10 San Francisco
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News 10/15/10 San Francisco
Exelixis Nabs $60M Upfront, Potentially $505M More, From New Deal With Bristol-Myers 10/11/10 San Francisco
Plexxikon Shows How New Drug Hits Molecular Target for Deadly Skin Cancer 09/07/10 San Francisco
Onyx Moving to South SF 07/14/10 San Francisco
Infinity Pharma, Intellikine Strike Deal to Make Cancer Drugs Against Hot Target 07/08/10 Boston
PhyloTech, Corey Goodman’s First Environmental Health Startup, Raises $1.2M in Seed Capital 07/06/10 San Francisco
Exelixis CEO Takes Biogen Gig, What Drives Brook Byers Crazy, The Mission Bay Biotech Cluster, & More Bay Area Life Sciences News 07/02/10 San Francisco
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
New CEO George Scangos Says Biogen Idec’s R&D Has to Improve 07/01/10 Boston
Exelixis Promotes Morrissey to CEO, Replacing Scangos as He Heads to Biogen Idec 06/30/10 San Francisco
Calistoga Pharmaceuticals Nabs $40M in Washington’s Biggest Venture Deal of 2010 06/30/10 Seattle
Genentech’s Souped-Up Antibody, Reg Kelly’s Mission, LS9 Nears Moment of Truth & More Bay Area Life Sciences News 06/25/10 San Francisco
Bristol-Myers Dumps Exelixis Drug 06/21/10 San Francisco
Calistoga Pharmaceuticals Builds Stronger Case for Blood Cancer Drug 06/07/10 Seattle
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets 08/18/09 San Diego
Intellikine, Chasing Hot Cancer Drug Target, Raises Big Venture Round 07/02/09 San Diego
Sanofi CEO Bets Outside U.S., Gears Up for Flu Pandemic, and Seeks To Learn From Biotech 06/19/09 Seattle
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News 06/04/09 Seattle
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results 06/01/09 Seattle
Calistoga Picks Up Buzz at ASCO, Thanks to Momentum from Rival 05/30/09 Seattle
Calistoga Raises $30M to Develop Drugs for Cancer, Inflammation 05/05/09 Seattle
Page 2 of 3 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.